Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 72.55 USD -1.51% Market Closed
Market Cap: 10B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one GMED stock under the Base Case scenario is 115.3 USD. Compared to the current market price of 72.55 USD, Globus Medical Inc is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMED Relative Value
Base Case
115.3 USD
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4
P/S
P/S
Price to Sales
4
vs History
93
vs Industry
30
Median 3Y
5.3
Median 5Y
6
Industry
2.2
Forward
3.6
More Details
96.8
P/E
P/E
Price to Earnings
96.8
vs History
19
vs Industry
4
Median 3Y
47.5
Median 5Y
48.2
Industry
22.5
Forward
20.7
More Details
19.1
P/OCF
P/OCF
Price to OCF
19.1
vs History
98
vs Industry
19
Median 3Y
29.8
Median 5Y
29.8
Industry
13.9
More Details
24.6
P/FCFE
P/FCFE
Price to FCFE
24.6
vs History
98
vs Industry
18
Median 3Y
45
Median 5Y
44.6
Industry
19.7
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
79
vs Industry
34
Median 3Y
2.9
Median 5Y
3.4
Industry
2.1
More Details
3.6
EV/S
EV/S
Enterprise Value to Sales
3.6
vs History
93
vs Industry
30
Median 3Y
4.8
Median 5Y
5.6
Industry
2.3
Forward
3.3
More Details
6.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.1
vs History
90
vs Industry
35
Median 3Y
7.2
Median 5Y
7.9
Industry
4.9
More Details
19.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.2
vs History
79
vs Industry
17
Median 3Y
21.1
Median 5Y
22.8
Industry
11.9
Forward
10.2
More Details
41.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
41.3
vs History
31
vs Industry
9
Median 3Y
33.2
Median 5Y
35
Industry
16.4
Forward
14.3
More Details
17.4
EV/OCF
EV/OCF
Enterprise Value to OCF
17.4
vs History
98
vs Industry
21
Median 3Y
28.3
Median 5Y
28.3
Industry
13.7
More Details
22.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.4
vs History
98
vs Industry
19
Median 3Y
43.4
Median 5Y
41.5
Industry
17.2
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
77
vs Industry
34
Median 3Y
3.1
Median 5Y
3.7
Industry
1.8
More Details

Multiples Across Competitors

GMED Competitors Multiples
Globus Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Globus Medical Inc
NYSE:GMED
10B USD 4 96.8 19.2 41.3
US
Abbott Laboratories
NYSE:ABT
226.5B USD 5.4 16.9 22.6 33.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.2B USD 21 75.4 58.4 70.8
US
Boston Scientific Corp
NYSE:BSX
146.4B USD 8.7 79 36.1 51
US
Stryker Corp
NYSE:SYK
139B USD 6.2 46.4 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
112.5B USD 3.4 26.4 14.1 19.9
US
Becton Dickinson and Co
NYSE:BDX
65.8B USD 3.2 37.7 15.7 28.3
DE
Siemens Healthineers AG
XETRA:SHL
57.1B EUR 2.5 28.8 16.4 23.4
US
Edwards Lifesciences Corp
NYSE:EW
41.8B USD 7.7 10 23.5 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
288.7B CNY 7.8 23.3 20.4 20.4
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.6B USD 1.9 18.4 12.9 15.7

See Also

Summary
GMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
GMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GMED stock valuation using valuation multiples.
Wall Street Estimates
GMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.